Media Partners

2026 Media Partners

Take a look at the media partners who decided to support the 7th Genome Editing Therapeutics Summit.

Advancing RNA

Advancing RNA is a Life Science Connect community focused on the rapidly evolving field of RNA-based therapeutics. It aims to provide valuable insights, discussions, and resources for professionals developing RNA-based drugs. Primary members of the community consist of individuals from biopharma organizations engaged in pre-BLA development, often in the pre-IND discovery stage. The community addresses various challenges in RNA therapy development, including analytical, quality, manufacturing, and regulatory issues. Additionally, Advancing RNA is positioned within the broader Life Science Connect network, allowing members to access additional resources as needed for their RNA therapy development journey.

BioPharma Asia

Learn more:

BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters associated with only end-user companies. So, ensuring the information will always be guaranteed to remain timely, informative, and unbiased.

www.biopharma-asia.com

Cell & Gene

Learn more:

Cell & Gene provides actionable information to professionals involved in the development and commercialization of cell and gene therapies. Through the original editorial published on the site — both staff-written and contributed (by subject-matter experts) — Cell & Gene facilitates the sharing of insights on challenges, trends, and best practices in this burgeoning field. Cell & Gene’s editorial scope spans the entire product lifecycle from basic research to commercialization.

Cell & Gene Therapy Insights

Learn more:

Translation-driven insights across the cell and gene therapy lifecycle

Cell & Gene Therapy Insights is an online, open-access, peer-reviewed journal dedicated to the interdisciplinary exploration and advancement of the field. Through our translational focus, we bridge academia and industry to support preclinical and clinical development, scale-up, and commercialization.

www.insights.bio/cell-and-gene-therapy-insights

Gene Therapy Net

Learn more:

Journal of Translational Genetics and Genomics

Learn more:

Aims and Scope

The Journal of Translational Genetics and Genomics focuses on basic and clinical research in human genetics, emphasizing molecular and clinical genetics, biochemistry, epigenetics, pharmacogenomics, molecular biology, and oncology. The journal welcomes submissions including Original Articles, Reviews, Short Communications, Commentaries, and Perspectives. We sincerely invite experts and scholars worldwide to submit manuscripts and collaborate!

Contact Us

Journal Website: www.oaepublish.com
Email: editorial@jtggjournal.com
Submission Portal: www.oaemesas.com/login?JournalId=jtgg

Journal Information:

Founded: 2017
ISSN (Online): 2578-5281
Impact Factor: 1.5; Citescore: 2.5
Publication Frequency: Quarterly
Publication Model: Gold Open Access
Indexed in: ESCI, Scopus, CAS, CNKI, ASCI
Honorary Editor-in-Chief: Prof. Li Jin, Member of the Chinese
Academy of Sciences, President of Fudan University
Editor-in-Chief: Prof. Sanjay Gupta, Case Western Reserve University, USA
Average Publication Time: 3 months

Life Science Review - Media Partner for the 7th Genome Editing Therapeutics Summit 2026

Life Sciences Review

Learn more:

Life Science Review Magazine is a print and digital magazine with a total subscription of 124,000 qualified subscribers consisting of senior decision-makers from Pharmaceutical, Biotech, Medical Device and Diagnostic space performing functions in Sales & Marketing, Manufacturing, Supply Chain, R&D, Clinical Operations, Finance, and HR. It provides a comprehensive platform for senior-level industry experts, acquirers, and decision-makers to share their insights following a unique peer learning approach.

www.lifesciencesreview.com